Back to video list Back to Home Is there a value of initiating a long-acting injectable if adherence might not be a concern? You may also like Parkinson's Disease Congress highlights Article Exercise and dopaminergic therapy for early Parkinson’s disease Depression Article The Impact of Pandemic Trauma: A Historical Perspective Depression Schizophrenia Article Expert Views New Approaches to Acute and Long-term Treatment of Schizophrenia Schizophrenia Article Videogames and Psychosis: Concerns versus Opportunities